Fusi A - Search Results

1

Treatment options in hormone-refractory metastatic prostate carcinoma.

Fusi A, Procopio G, Della Torre S, Ricotta R, Bianchini G, Salvioni R, Ferrari L, Martinetti A, Savelli G, Villa S, Bajetta E. Fusi A, et al. Tumori. 2004 Nov-Dec;90(6):535-46. doi: 10.1177/030089160409000601. Tumori. 2004. PMID: 15762353 Review.

2

Current treatments of neuroendocrine tumors role of biotherapy and chemotherapy.

Della Torre S, Procopio G, Fusi A, Catena L, Ferrari L, Nova P, Denaro A, Bichisao E, Bajetta E. Della Torre S, et al. Among authors: fusi a. Tumori. 2003 Mar-Apr;89(2):111-6. doi: 10.1177/030089160308900201. Tumori. 2003. PMID: 12841654 Review.

3

Neuroendocrine tumors of the larynx: a clinical report and literature review.

Procopio G, Ricotta R, Fusi A, Celio L, De Dosso S, Catena L, Ferrari L, Quattrone P, Verzoni E, Bajetta E. Procopio G, et al. Among authors: fusi a. Tumori. 2006 Jan-Feb;92(1):72-5. Tumori. 2006. PMID: 16683387

4

Oxaliplatin doublets in non-small cell lung cancer: a literature review.

Cortinovis D, Bidoli P, Zilembo N, Fusi A, Bajetta E. Cortinovis D, et al. Among authors: fusi a. Lung Cancer. 2008 Jun;60(3):325-31. doi: 10.1016/j.lungcan.2008.03.005. Epub 2008 Apr 25. Lung Cancer. 2008. PMID: 18440088 Review.

5

Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?

Cortinovis D, Bidoli P, Cullurà D, Lorusso V, Ardizzoia A, Amoroso V, Bandera M, Aitini E, Fusi A, Zilembo N, Radula D, Bajetta E. Cortinovis D, et al. Among authors: fusi a. J Thorac Oncol. 2008 Apr;3(4):405-11. doi: 10.1097/JTO.0b013e318168f780. J Thorac Oncol. 2008. PMID: 18379360 Free article. Clinical Trial.

6

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine.

Liu Z, Fusi A, Schmittel A, Tinhofer I, Schneider A, Keilholz U. Liu Z, et al. Among authors: fusi a. Cancer Biol Ther. 2010 Nov 1;10(9):860-4. doi: 10.4161/cbt.10.9.13323. Epub 2010 Nov 1. Cancer Biol Ther. 2010. PMID: 20855957 Free article.

7

Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: a phase II study.

Ferrari VD, Amoroso V, Valcamonico F, Fusi A, Simoncini E, Vasalli L, Rangoni G, Mambrini A, Marpicati P, Montini E, Marini G. Ferrari VD, et al. Among authors: fusi a. Am J Clin Oncol. 2004 Oct;27(5):445-8. doi: 10.1097/01.coc.0000128722.41587.19. Am J Clin Oncol. 2004. PMID: 15596907 Clinical Trial.

8

Biclonal non-small cell lung cancer in disseminated tumor cells and tissue.

Puggina A, Kümmerlen V, Jöhrens-Leder K, Keilholz U, Fusi A. Puggina A, et al. Among authors: fusi a. J Thorac Oncol. 2012 Jul;7(7):1202-3. doi: 10.1097/JTO.0b013e318257095a. J Thorac Oncol. 2012. PMID: 22706609 Free article. No abstract available.

9

Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer.

Howell M, Lee R, Bowyer S, Fusi A, Lorigan P. Howell M, et al. Among authors: fusi a. Lung Cancer. 2015 May;88(2):117-23. doi: 10.1016/j.lungcan.2015.02.007. Epub 2015 Feb 16. Lung Cancer. 2015. PMID: 25776466 Review.

10

Clinical utility of circulating tumour cell detection in non-small-cell lung cancer.

Fusi A, Metcalf R, Krebs M, Dive C, Blackhall F. Fusi A, et al. Curr Treat Options Oncol. 2013 Dec;14(4):610-22. doi: 10.1007/s11864-013-0253-5. Curr Treat Options Oncol. 2013. PMID: 23996475 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters